| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.45 | $40.16 (0%) | 🛒 Add to cart |
| 120 | $0.37 | $53.55 $44.18 (18%) | 🛒 Add to cart |
| 180 | $0.30 | $80.33 $54.22 (32%) | 🛒 Add to cart |
| 360 | $0.22
Best per pill | $160.66 $79.32 (51%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.18 (0%) | 🛒 Add to cart |
| 90 | $0.55 | $64.77 $49.20 (24%) | 🛒 Add to cart |
| 120 | $0.46 | $86.35 $55.23 (36%) | 🛒 Add to cart |
| 180 | $0.38 | $129.53 $68.28 (47%) | 🛒 Add to cart |
| 270 | $0.32 | $194.30 $86.35 (56%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $259.06 $104.43 (60%) | 🛒 Add to cart |
| Product dosage: 750mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.97 | $59.24 (0%) | 🛒 Add to cart |
| 60 | $1.39 | $118.49 $83.34 (30%) | 🛒 Add to cart |
| 90 | $1.18 | $177.73 $106.44 (40%) | 🛒 Add to cart |
| 120 | $1.09 | $236.97 $130.53 (45%) | 🛒 Add to cart |
| 180 | $0.99 | $355.46 $177.73 (50%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $710.91 $318.30 (55%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
Cipro: Potent Antibacterial Therapy for Resistant Infections - Evidence-Based Review
Ciprofloxacin, commonly referred to as Cipro, is a broad-spectrum fluoroquinolone antibiotic that has been a cornerstone in treating bacterial infections since its introduction in the 1980s. It’s available in oral tablets, intravenous formulations, and ophthalmic/otic solutions, targeting a wide range of gram-positive and gram-negative pathogens. Its significance in modern medicine stems from its potent activity against difficult-to-treat infections, including those resistant to other antibiotics, though its use has become more nuanced due to emerging safety concerns.
Ciprodex Ophthalmic Solution: Comprehensive Anti-Infective and Anti-Inflammatory Action for External Ocular Infections
Ciprodex ophthalmic solution represents one of those rare formulations where the combination therapy actually delivers superior clinical outcomes compared to either component alone. I’ve been using it in my ophthalmology practice for over a decade now, and the evolution in how we approach external ocular infections has been remarkable. This antibiotic-steroid combination addresses the fundamental challenge in ocular infection management: controlling the infectious process while simultaneously managing the inflammatory response that can cause as much damage as the infection itself.
Besivance Ophthalmic Solution: Effective Bacterial Conjunctivitis Treatment - Evidence-Based Review
Besivance ophthalmic solution is a sterile, topical antibiotic eye drop specifically formulated for treating bacterial conjunctivitis. It contains besifloxacin, a broad-spectrum fluoroquinolone, in a concentration of 0.6% (6 mg/mL). The solution is preserved with sodium perborate, which breaks down into hydrogen peroxide and borate, and is formulated in a mucoadhesive polymer base (DuraSite®) that extends the drug’s contact time with the ocular surface. This isn’t your standard, run-of-the-mill drop; it’s a purpose-built weapon against common and resistant ocular pathogens.
Ciloxan Ophthalmic Solution: Effective Bacterial Conjunctivitis and Corneal Ulcer Treatment - Evidence-Based Review
Ciloxan ophthalmic solution is a sterile, preservative-free topical antibiotic formulation specifically designed for ocular infections. It contains ciprofloxacin hydrochloride, a broad-spectrum fluoroquinolone, at a concentration equivalent to 0.3% ciprofloxacin. The solution comes in 5mL dropper bottles and is indicated for bacterial conjunctivitis and corneal ulcers caused by susceptible organisms. What makes it particularly valuable in ophthalmic practice is its activity against both gram-positive and gram-negative bacteria, including some strains of Pseudomonas aeruginosa – a notoriously difficult pathogen in corneal infections.
ciplox
Ciprofloxacin, commonly encountered in clinical practice as Ciplox, represents a cornerstone fluoroquinolone antibiotic with a broad spectrum of activity against Gram-positive and Gram-negative bacteria. Its development marked a significant advancement in antimicrobial therapy, particularly for complex infections where other classes had begun to fail. We’ve relied on it for decades in hospital and community settings, but its use requires a nuanced understanding that only comes from seeing its effects—both intended and unintended—across hundreds of patient cases.
clozaril
Clozaril represents one of the most significant advances in treatment-resistant schizophrenia management, yet remains widely misunderstood even among experienced clinicians. When I first encountered this medication during my residency at Massachusetts General, the hematological monitoring requirements seemed so burdensome we almost avoided using it entirely - a decision that would have profoundly impacted dozens of patients I’ve since treated successfully. Clozaril: Breakthrough Treatment for Treatment-Resistant Schizophrenia - Evidence-Based Review 1. Introduction: What is Clozaril?
coumadin
Warfarin, marketed under the brand name Coumadin among others, is one of the oldest and most widely prescribed anticoagulant medications globally. It’s a vitamin K antagonist that fundamentally alters the body’s clotting cascade, preventing the formation of harmful blood clots. For decades, it has been the cornerstone of therapy for conditions like atrial fibrillation, mechanical heart valves, and deep vein thrombosis, despite the emergence of newer agents. Its management is notoriously complex, requiring meticulous dosing and frequent monitoring of the International Normalized Ratio (INR) to balance the fine line between preventing thrombosis and avoiding hemorrhage.
Daliresp: Reducing COPD Exacerbations Through Targeted Anti-Inflammatory Action - Evidence-Based Review
Daliresp, known generically as roflumilast, is a selective phosphodiesterase-4 (PDE4) inhibitor approved as an oral tablet for reducing the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations. It’s not a bronchodilator but works through a distinct anti-inflammatory pathway, which makes it a unique option in the COPD treatment arsenal. 1. Introduction: What is Daliresp? Its Role in Modern Medicine What is Daliresp?
Floxin: Potent Broad-Spectrum Antibiotic for Resistant Infections - Evidence-Based Review
Of course. Here is the comprehensive, evidence-based product monograph for “Floxin,” written in the requested style and format. Floxin, with the generic name ofloxacin, is a second-generation synthetic fluoroquinolone antibiotic. It’s a cornerstone in the arsenal against a wide range of bacterial pathogens, particularly those demonstrating resistance to older antibiotic classes. Its development in the 1980s was a significant step forward, offering an oral agent with a spectrum of activity that, at the time, was largely the domain of intravenous medications.